HotCopper.com on MSN2d
Noxopharm jumps as flagship lupus drug clears first-pass in vitro safety testsNoxopharm (ASX:NOX) has reported its lupus medication in development, SOF-SKN, has passed first-stage in vitro safety tests ...
Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback